@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix RNA: . @prefix mgi: . @prefix geneProductOf: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:2443731; a RNA: . sub:_2 occursIn: species:10090; rdf:object sub:_1; rdf:predicate belv:decreases; rdf:subject go:0016573; a rdf:Statement . sub:assertion rdfs:label "bp(GO:\"histone acetylation\") -| r(MGI:Mat2a)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "Mat2a promoter is hypomethylated in hepatocellular carcinoma, in which the gene is upregulated transcriptionally, but hypermethylated in normal liver, in which the gene is minimally expressed treatment of adult rat and human hepatocytes with trichostatin A, an inhibitor or histone deacetylase, upregulated Mat2a expression by more than fourfold these results suggest that Mat2a expression is regulated by promoter methylation and histone acetylation"; prov:wasQuotedFrom pubmed:11208539 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:11208539; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:54.300+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }